~~<i id='8645A73A7D'><strike id='8645A73A7D'><tt id='8645A73A7D'><pre id='8645A73A7D'></pre></tt></strike></i>~~

Home» leisure time» entertainment

entertainment

author：comprehensive 2025-10-02 02:39:54 Page View：76

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

explore

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Biden White House, tech companies launch new safeguards around emerging AI technology

5:47PresidentJoeBidenspeaksaboutartificialintelligenceintheRooseveltRoomoftheWhiteHouse,July2,2023.M

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

South Korea throws huge K

1:30AttendeesoftheWorldScoutJamboreewatchaK-PopconcertaftertheclosingceremonyoftheWorldScoutJamboree